Heliox21 Via FM Guideline VJB 13mar07
Heliox21 Via FM Guideline VJB 13mar07
Heliox21 Via FM Guideline VJB 13mar07
Indications
Helium oxygen mixtures should be considered as a rescue therapy in the immediate management of such
conditions as: Croup, Epiglottitis, Laryngitis, Tracheitis, Stridor, Foreign body aspiration, Post extubation or
peri bronchoscopy stridor, Tumour (upper airway or proximal tracheobronchial tree), Tracheomalacia,
Tracheal stenosis, Acute severe asthma, Acute severe (hypercapnic) exacerbation of COPD. Treatment
with a helium oxygen mixture should be initiated in a patient with any of these conditions who despite first
line therapy develops severe respiratory distress, specifically: reports severe dyspnoea, has a very high
respiratory rate, is making excessive respiratory effort, is tiring, becomes drowsy or agitated, is becoming
hypoxic and / or hypercapnic.
Expected effects
Administering helium oxygen should improve the efficiency of ventilation and thereby reduce respiratory
distress. It is only a temporising intervention i.e. it extends the period of time available for definite treatment
for the underlying condition to be delivered, it is not in itself therapeutic.
Safety
Standard safety precautions for compressed gases are all that is required. Helium is inert and insoluble in
human tissues at atmospheric pressure. Helium does have a high thermal conductivity but does not cause
patient cooling even in neonates.
Interactions
None
Advice to Patients
None
To administer He:O2 79:21 To increase the FiO2 add O2 via To administer nebulised therapy,
connect reservoir bag to HX the connector provided (on the attach the chamber as shown.
cylinder at a flow rate of 8- left). Titrate the O2 flow rate to The chamber can be driven by
15L/min. The flow rate should be achieve an SpO2 of 88-92% either Heliox21 set at 15 L/min or
enough to maintain reservoir bag O2 set at 8 L/min. Use Heliox21 if
distension SpO2 is ≥ 88%, otherwise use O2.
The reason for the different flow
rates is that Heliox21 is less
efficient at aerosol generation than
O2.
For further information please contact Dr Jonathan Ball on GICU, or in an emergency, any senior member of
the GICU team.